Search by Drug Name or NDC
NDC 70183-0220-30 INPEFA 200 mg/1 Details
INPEFA 200 mg/1
INPEFA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lexicon Pharmaceuticals, Inc.. The primary component is SOTAGLIFLOZIN.
MedlinePlus Drug Summary
Sotagliflozin is used to reduce the risk of a stroke, heart attack, or death or hospitalization for heart failure or urgent visits for heart failure-related concerns in adults who have heart failure or type 2 diabetes or chronic kidney disease along with heart and blood vessel disease. Sotagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works to help heart failure by causing the kidneys to get rid of sodium and glucose which helps the heart to function better. It is unclear how it works to reduce risk of heart attack or stroke or death from cardiac or vascular disease.
Related Packages: 70183-0220-30Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Sotagliflozin
Product Information
| NDC | 70183-0220 |
|---|---|
| Product ID | 70183-220_8c3687e7-b8b3-4586-976b-98035bb896ac |
| Associated GPIs | |
| GCN Sequence Number | 084849 |
| GCN Sequence Number Description | sotagliflozin TABLET 200 MG ORAL |
| HIC3 | C4D |
| HIC3 Description | ANTIHYPERGLYCEMIC-SOD/GLUC COTRANSPORT2(SGLT2) INH |
| GCN | 54239 |
| HICL Sequence Number | 048976 |
| HICL Sequence Number Description | SOTAGLIFLOZIN |
| Brand/Generic | Brand |
| Proprietary Name | INPEFA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | sotagliflozin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | SOTAGLIFLOZIN |
| Labeler Name | Lexicon Pharmaceuticals, Inc. |
| Pharmaceutical Class | P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA216203 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70183-0220-30 (70183022030)
| NDC Package Code | 70183-220-30 |
|---|---|
| Billing NDC | 70183022030 |
| Package | 30 TABLET in 1 BOTTLE (70183-220-30) |
| Marketing Start Date | 2023-05-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |